ArticleInternal and emergency medicine2026
Sex differences in vascular endothelial function in predicting cardiovascular events in hypertensive patients.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sex differences in vascular endothelial function in predicting cardiovascular events in hypertensive patients: comment.Internal and emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of cardiovascular morbidity and mortality is higher in females than in males, probably for different pathogenetic mechanisms operating in the onset and progression of atherosclerotic vascular disease. Endothelial dysfunction is also recognized as an important and independent predictor of cardiovascular events. Thus, we designed this study to detect possible differences in endothelial function between sexes and their effect on cardiovascular prognosis. We enrolled 844 Caucasian hypertensives (451 males and 393 females, aged 49.5 + 10.9 years). Endothelial function was investigated by strain-gauge plethysmography. Compared with males, females showed a significantly lower endothelium-dependent vasodilation (acetylcholine-stimulated peak percent increase 268 ± 1113 vs 309 ± 108% increase from basal). During the follow-up period of 9.3 ± 3.2 years, 252 new fatal and non-fatal cardiovascular outcomes (3.20%) occurred: 151 coronary (1.92%), 61 cerebrovascular (0.77%), and 40 deaths (0.51%), with a higher incidence in females than in males [MACE (3.79 vs 2.68%; P = 0.001) and coronary events (2.24 vs 1.69%; P = 0.035), cerebrovascular events (0.93 vs 0.64%; P = 0.135) and all-cause mortality (0.63 vs 0.40%; P = 0.155)]. In multivariate Cox regression analysis, endothelial function resulted an independent predictor of MACE (HR = 0.82; 95% CI 0.73-0.952) and coronary events (HR = 0.81; 95% CI 0.69-0.95), together with hs-CRP, age, LDL-cholesterol and triglyceride in the whole population, and in females and males, separately. These results were also confirmed in ROC analysis, that demonstrated a different cut-off value of endothelial function between groups (275% for males, 214% for females). Our results confirm, in hypertensive patients, the existence of significant differences between sexes in the occurrence of cardiovascular events, probably attributable to a lower vasodilating property of vascular endothelium in females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.